Read More Analyst Ratings News Price Target B of A Securities Maintains Neutral on Editas Medicine, Lowers Price Target to $15 By Benzinga Newsdesk Today, 5:30 AM B of A Securities analyst Greg Harrison maintains Editas Medicine (NASDAQ:EDIT) with a Neutral and lowers the price target from $18 to $15. EDIT
Read More Earnings Guidance News Allegion Q4 Results Surpass Expectation; Names Michael Wagnes As Finance Chief By Akanksha Bakshi Today, 5:30 AM Allegion PLC (NYSE:ALLE) reported a fourth-quarter FY21 revenue decline of 2.5% year-over-year to $709.2 million, -1.4% on an organic basis, beating… ALLE
Read More General News Politics White House’s Kirby Says Biden Will Continue To Evaluate Market Needs As Appropriate Regarding Oil By Benzinga Newsdesk Today, 5:30 AM -Reuters SPY
Read More Econ #s Federal Reserve News SF Fed’s Mary Daly Said Have an Open Mind if 75 Bps Rate Hike Will Be Needed in Sept; My Baseline is for 50 Bps Hike in Sept By Charles Gross Today, 5:30 AM -Bloomberg Interview SPY